Application 207947
- Type
- NDA
- Sponsor
- ACTELION PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | UPTRAVI | SELEXIPAG | TABLET;ORAL | 0.2MG | Yes | No |
| 002 | UPTRAVI | SELEXIPAG | TABLET;ORAL | 0.4MG | Yes | Yes |
| 003 | UPTRAVI | SELEXIPAG | TABLET;ORAL | 0.6MG | Yes | No |
| 004 | UPTRAVI | SELEXIPAG | TABLET;ORAL | 0.8MG | Yes | No |
| 005 | UPTRAVI | SELEXIPAG | TABLET;ORAL | 1MG | Yes | No |
| 006 | UPTRAVI | SELEXIPAG | TABLET;ORAL | 1.2MG | Yes | No |
| 007 | UPTRAVI | SELEXIPAG | TABLET;ORAL | 1.4MG | Yes | No |
| 008 | UPTRAVI | SELEXIPAG | TABLET;ORAL | 1.6MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N207947-001 | UPTRAVI | SELEXIPAG | 0.2MG | TABLET / ORAL | AB | RLD | 2015-12-21 |
| N207947-002 | UPTRAVI | SELEXIPAG | 0.4MG | TABLET / ORAL | AB | RLD, RS | 2015-12-21 |
| N207947-003 | UPTRAVI | SELEXIPAG | 0.6MG | TABLET / ORAL | AB | RLD | 2015-12-21 |
| N207947-004 | UPTRAVI | SELEXIPAG | 0.8MG | TABLET / ORAL | AB | RLD | 2015-12-21 |
| N207947-005 | UPTRAVI | SELEXIPAG | 1MG | TABLET / ORAL | AB | RLD | 2015-12-21 |
| N207947-006 | UPTRAVI | SELEXIPAG | 1.2MG | TABLET / ORAL | AB | RLD | 2015-12-21 |
| N207947-007 | UPTRAVI | SELEXIPAG | 1.4MG | TABLET / ORAL | AB | RLD | 2015-12-21 |
| N207947-008 | UPTRAVI | SELEXIPAG | 1.6MG | TABLET / ORAL | AB | RLD | 2015-12-21 |
| N207947-010 | UPTRAVI | SELEXIPAG | 0.1MG | TABLET / ORAL | RLD | 2026-05-23 | |
| N207947-011 | UPTRAVI | SELEXIPAG | 0.15MG | TABLET / ORAL | RLD | 2026-05-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N207947-001 | AB |
| N207947-002 | AB |
| N207947-003 | AB |
| N207947-004 | AB |
| N207947-005 | AB |
| N207947-006 | AB |
| N207947-007 | AB |
| N207947-008 | AB |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N207947-001 | 7205302 | 2026-10-31 | U-1797 | Drug substance, Drug product | 2016-01-19 |
| N207947-001 | 7205302*PED | 2027-04-30 | Pediatric extension | ||
| N207947-001 | 9173881 | 2029-08-12 | U-1798 | 2016-01-19 | |
| N207947-001 | 9173881*PED | 2030-02-12 | Pediatric extension | ||
| N207947-001 | 9284280 | 2030-06-25 | U-1831 | 2016-04-12 | |
| N207947-001 | 8791122 | 2030-08-01 | Drug substance, Drug product | 2016-01-19 | |
| N207947-001 | 9284280*PED | 2030-12-25 | Pediatric extension | ||
| N207947-001 | 8791122*PED | 2031-02-01 | Pediatric extension | ||
| N207947-001 | 10821108 | 2036-12-01 | U-2992 | Drug product | 2020-12-02 |
| N207947-001 | 10828298 | 2036-12-01 | U-2991 | Drug product | 2020-12-02 |
| N207947-001 | 10821108*PED | 2037-06-01 | Pediatric extension | ||
| N207947-001 | 10828298*PED | 2037-06-01 | Pediatric extension | ||
| N207947-002 | 7205302 | 2026-10-31 | U-1797 | Drug substance, Drug product | 2016-01-19 |
| N207947-002 | 7205302*PED | 2027-04-30 | Pediatric extension | ||
| N207947-002 | 9173881 | 2029-08-12 | U-1798 | 2016-01-19 | |
| N207947-002 | 9173881*PED | 2030-02-12 | Pediatric extension | ||
| N207947-002 | 9284280 | 2030-06-25 | U-1831 | 2016-04-12 | |
| N207947-002 | 8791122 | 2030-08-01 | Drug substance, Drug product | 2016-01-19 | |
| N207947-002 | 9284280*PED | 2030-12-25 | Pediatric extension | ||
| N207947-002 | 8791122*PED | 2031-02-01 | Pediatric extension | ||
| N207947-002 | 10821108 | 2036-12-01 | U-2992 | Drug product | 2020-12-02 |
| N207947-002 | 10828298 | 2036-12-01 | U-2991 | Drug product | 2020-12-02 |
| N207947-002 | 10821108*PED | 2037-06-01 | Pediatric extension | ||
| N207947-002 | 10828298*PED | 2037-06-01 | Pediatric extension | ||
| N207947-003 | 7205302 | 2026-10-31 | U-1797 | Drug substance, Drug product | 2016-01-19 |
| N207947-003 | 7205302*PED | 2027-04-30 | Pediatric extension | ||
| N207947-003 | 9173881 | 2029-08-12 | U-1798 | 2016-01-19 | |
| N207947-003 | 9173881*PED | 2030-02-12 | Pediatric extension | ||
| N207947-003 | 9284280 | 2030-06-25 | U-1831 | 2016-04-12 | |
| N207947-003 | 8791122 | 2030-08-01 | Drug substance, Drug product | 2016-01-19 | |
| N207947-003 | 9284280*PED | 2030-12-25 | Pediatric extension | ||
| N207947-003 | 8791122*PED | 2031-02-01 | Pediatric extension | ||
| N207947-003 | 10821108 | 2036-12-01 | U-2992 | Drug product | 2020-12-02 |
| N207947-003 | 10828298 | 2036-12-01 | U-2991 | Drug product | 2020-12-02 |
| N207947-003 | 10821108*PED | 2037-06-01 | Pediatric extension | ||
| N207947-003 | 10828298*PED | 2037-06-01 | Pediatric extension | ||
| N207947-004 | 7205302 | 2026-10-31 | U-1797 | Drug substance, Drug product | 2016-01-19 |
| N207947-004 | 7205302*PED | 2027-04-30 | Pediatric extension | ||
| N207947-004 | 9173881 | 2029-08-12 | U-1798 | 2016-01-19 | |
| N207947-004 | 9173881*PED | 2030-02-12 | Pediatric extension | ||
| N207947-004 | 9284280 | 2030-06-25 | U-1831 | 2016-04-12 | |
| N207947-004 | 8791122 | 2030-08-01 | Drug substance, Drug product | 2016-01-19 | |
| N207947-004 | 9284280*PED | 2030-12-25 | Pediatric extension | ||
| N207947-004 | 8791122*PED | 2031-02-01 | Pediatric extension | ||
| N207947-004 | 10821108 | 2036-12-01 | U-2992 | Drug product | 2020-12-02 |
| N207947-004 | 10828298 | 2036-12-01 | U-2991 | Drug product | 2020-12-02 |
| N207947-004 | 10821108*PED | 2037-06-01 | Pediatric extension | ||
| N207947-004 | 10828298*PED | 2037-06-01 | Pediatric extension | ||
| N207947-005 | 7205302 | 2026-10-31 | U-1797 | Drug substance, Drug product | 2016-01-19 |
| N207947-005 | 7205302*PED | 2027-04-30 | Pediatric extension | ||
| N207947-005 | 9173881 | 2029-08-12 | U-1798 | 2016-01-19 | |
| N207947-005 | 9173881*PED | 2030-02-12 | Pediatric extension | ||
| N207947-005 | 9284280 | 2030-06-25 | U-1831 | 2016-04-12 | |
| N207947-005 | 8791122 | 2030-08-01 | Drug substance, Drug product | 2016-01-19 | |
| N207947-005 | 9284280*PED | 2030-12-25 | Pediatric extension | ||
| N207947-005 | 8791122*PED | 2031-02-01 | Pediatric extension | ||
| N207947-005 | 10821108 | 2036-12-01 | U-2992 | Drug product | 2020-12-02 |
| N207947-005 | 10828298 | 2036-12-01 | U-2991 | Drug product | 2020-12-02 |
| N207947-005 | 10821108*PED | 2037-06-01 | Pediatric extension | ||
| N207947-005 | 10828298*PED | 2037-06-01 | Pediatric extension | ||
| N207947-006 | 7205302 | 2026-10-31 | U-1797 | Drug substance, Drug product | 2016-01-19 |
| N207947-006 | 7205302*PED | 2027-04-30 | Pediatric extension | ||
| N207947-006 | 9173881 | 2029-08-12 | U-1798 | 2016-01-19 | |
| N207947-006 | 9173881*PED | 2030-02-12 | Pediatric extension | ||
| N207947-006 | 9284280 | 2030-06-25 | U-1831 | 2016-04-12 | |
| N207947-006 | 8791122 | 2030-08-01 | Drug substance, Drug product | 2016-01-19 | |
| N207947-006 | 9284280*PED | 2030-12-25 | Pediatric extension | ||
| N207947-006 | 8791122*PED | 2031-02-01 | Pediatric extension | ||
| N207947-006 | 10821108 | 2036-12-01 | U-2992 | Drug product | 2020-12-02 |
| N207947-006 | 10828298 | 2036-12-01 | U-2991 | Drug product | 2020-12-02 |
| N207947-006 | 10821108*PED | 2037-06-01 | Pediatric extension | ||
| N207947-006 | 10828298*PED | 2037-06-01 | Pediatric extension | ||
| N207947-007 | 7205302 | 2026-10-31 | U-1797 | Drug substance, Drug product | 2016-01-19 |
| N207947-007 | 7205302*PED | 2027-04-30 | Pediatric extension | ||
| N207947-007 | 9173881 | 2029-08-12 | U-1798 | 2016-01-19 | |
| N207947-007 | 9173881*PED | 2030-02-12 | Pediatric extension | ||
| N207947-007 | 9284280 | 2030-06-25 | U-1831 | 2016-04-12 | |
| N207947-007 | 8791122 | 2030-08-01 | Drug substance, Drug product | 2016-01-19 | |
| N207947-007 | 9284280*PED | 2030-12-25 | Pediatric extension | ||
| N207947-007 | 8791122*PED | 2031-02-01 | Pediatric extension |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N207947-001 | NPP | 2029-05-23 |
| N207947-001 | PED | 2029-11-23 |
| N207947-002 | NPP | 2029-05-23 |
| N207947-002 | PED | 2029-11-23 |
| N207947-003 | NPP | 2029-05-23 |
| N207947-003 | PED | 2029-11-23 |
| N207947-004 | NPP | 2029-05-23 |
| N207947-004 | PED | 2029-11-23 |
| N207947-005 | NPP | 2029-05-23 |
| N207947-005 | PED | 2029-11-23 |
| N207947-006 | NPP | 2029-05-23 |
| N207947-006 | PED | 2029-11-23 |
| N207947-007 | NPP | 2029-05-23 |
| N207947-007 | PED | 2029-11-23 |
| N207947-008 | NPP | 2029-05-23 |
| N207947-008 | PED | 2029-11-23 |
| N207947-010 | NS | 2029-05-23 |
| N207947-010 | PED | 2029-11-23 |
| N207947-011 | NS | 2029-05-23 |
| N207947-011 | PED | 2029-11-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | UPTRAVI | 0.2MG | TABLET / ORAL | AB | RLD | 2015-12-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | UPTRAVI | 0.4MG | TABLET / ORAL | AB | RLD, RS | 2015-12-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | UPTRAVI | 0.6MG | TABLET / ORAL | AB | RLD | 2015-12-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-004 | UPTRAVI | 0.8MG | TABLET / ORAL | AB | RLD | 2015-12-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-005 | UPTRAVI | 1MG | TABLET / ORAL | AB | RLD | 2015-12-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-006 | UPTRAVI | 1.2MG | TABLET / ORAL | AB | RLD | 2015-12-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-007 | UPTRAVI | 1.4MG | TABLET / ORAL | AB | RLD | 2015-12-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-008 | UPTRAVI | 1.6MG | TABLET / ORAL | AB | RLD | 2015-12-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-010 | UPTRAVI | 0.1MG | TABLET / ORAL | RLD | 2026-05-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207947-011 | UPTRAVI | 0.15MG | TABLET / ORAL | RLD | 2026-05-23 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207947-001 | UPTRAVI | 0.2MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N207947-002 | UPTRAVI | 0.4MG | TABLET / ORAL | AB | RLD, RS | 2015-12-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N207947-003 | UPTRAVI | 0.6MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N207947-004 | UPTRAVI | 0.8MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N207947-005 | UPTRAVI | 1MG | TABLET / ORAL | RLD | 2015-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207947-006 | UPTRAVI | 1.2MG | TABLET / ORAL | RLD | 2015-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207947-007 | UPTRAVI | 1.4MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N207947-008 | UPTRAVI | 1.6MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207947-001 | UPTRAVI | 0.2MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207947-002 | UPTRAVI | 0.4MG | TABLET / ORAL | AB | RLD, RS | 2015-12-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207947-003 | UPTRAVI | 0.6MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207947-004 | UPTRAVI | 0.8MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207947-005 | UPTRAVI | 1MG | TABLET / ORAL | RLD | 2015-12-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207947-006 | UPTRAVI | 1.2MG | TABLET / ORAL | RLD | 2015-12-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207947-007 | UPTRAVI | 1.4MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207947-008 | UPTRAVI | 1.6MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N207947-001 | UPTRAVI | 0.2MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N207947-002 | UPTRAVI | 0.4MG | TABLET / ORAL | AB | RLD, RS | 2015-12-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N207947-003 | UPTRAVI | 0.6MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N207947-004 | UPTRAVI | 0.8MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N207947-005 | UPTRAVI | 1MG | TABLET / ORAL | RLD | 2015-12-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207947-006 | UPTRAVI | 1.2MG | TABLET / ORAL | RLD | 2015-12-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207947-007 | UPTRAVI | 1.4MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N207947-008 | UPTRAVI | 1.6MG | TABLET / ORAL | AB | RLD | 2015-12-21 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207947-001 | UPTRAVI | 0.2MG | TABLET / ORAL | AB | RLD | 2015-12-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207947-002 | UPTRAVI | 0.4MG | TABLET / ORAL | AB | RLD, RS | 2015-12-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207947-003 | UPTRAVI | 0.6MG | TABLET / ORAL | AB | RLD | 2015-12-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207947-004 | UPTRAVI | 0.8MG | TABLET / ORAL | AB | RLD | 2015-12-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207947-005 | UPTRAVI | 1MG | TABLET / ORAL | RLD | 2015-12-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207947-006 | UPTRAVI | 1.2MG | TABLET / ORAL | RLD | 2015-12-21 | fd3edfee7708… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-005 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-006 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-007 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-008 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N207947-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N207947-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N207947-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N207947-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N207947-007 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N207947-008 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207947-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207947-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207947-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207947-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207947-007 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207947-008 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N207947-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N207947-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N207947-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N207947-004 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N207947-007 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N207947-008 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207947-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207947-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207947-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207947-004 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207947-007 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207947-008 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207947-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207947-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207947-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207947-004 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207947-007 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207947-008 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207947-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207947-002 | AB | 1 | 03ed91905a0d… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | 7205302 | 2026-10-31 | U-1797 | Drug substance, Drug product | 2016-01-19 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | 7205302*PED | 2027-04-30 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | 9173881 | 2029-08-12 | U-1798 | 2016-01-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | 9173881*PED | 2030-02-12 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | 9284280 | 2030-06-25 | U-1831 | 2016-04-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | 8791122 | 2030-08-01 | Drug substance, Drug product | 2016-01-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | 9284280*PED | 2030-12-25 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | 8791122*PED | 2031-02-01 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | 10821108 | 2036-12-01 | U-2992 | Drug product | 2020-12-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | 10828298 | 2036-12-01 | U-2991 | Drug product | 2020-12-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | 10821108*PED | 2037-06-01 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | 10828298*PED | 2037-06-01 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | 7205302 | 2026-10-31 | U-1797 | Drug substance, Drug product | 2016-01-19 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | 7205302*PED | 2027-04-30 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | 9173881 | 2029-08-12 | U-1798 | 2016-01-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | 9173881*PED | 2030-02-12 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | 9284280 | 2030-06-25 | U-1831 | 2016-04-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | 8791122 | 2030-08-01 | Drug substance, Drug product | 2016-01-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | 9284280*PED | 2030-12-25 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | 8791122*PED | 2031-02-01 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | 10821108 | 2036-12-01 | U-2992 | Drug product | 2020-12-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | 10828298 | 2036-12-01 | U-2991 | Drug product | 2020-12-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | 10821108*PED | 2037-06-01 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | 10828298*PED | 2037-06-01 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | 7205302 | 2026-10-31 | U-1797 | Drug substance, Drug product | 2016-01-19 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | 7205302*PED | 2027-04-30 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | 9173881 | 2029-08-12 | U-1798 | 2016-01-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | 9173881*PED | 2030-02-12 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | 9284280 | 2030-06-25 | U-1831 | 2016-04-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | 8791122 | 2030-08-01 | Drug substance, Drug product | 2016-01-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | 9284280*PED | 2030-12-25 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | 8791122*PED | 2031-02-01 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | 10821108 | 2036-12-01 | U-2992 | Drug product | 2020-12-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | 10828298 | 2036-12-01 | U-2991 | Drug product | 2020-12-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | 10821108*PED | 2037-06-01 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | 10828298*PED | 2037-06-01 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-004 | 7205302 | 2026-10-31 | U-1797 | Drug substance, Drug product | 2016-01-19 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-004 | 7205302*PED | 2027-04-30 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N207947-004 | 9173881 | 2029-08-12 | U-1798 | 2016-01-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207947-004 | 9173881*PED | 2030-02-12 | Pediatric extension | caaa826d4ba7… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | NPP | 2029-05-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-001 | PED | 2029-11-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | NPP | 2029-05-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-002 | PED | 2029-11-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | NPP | 2029-05-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-003 | PED | 2029-11-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-004 | NPP | 2029-05-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-004 | PED | 2029-11-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-005 | NPP | 2029-05-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-005 | PED | 2029-11-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-006 | NPP | 2029-05-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-006 | PED | 2029-11-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-007 | NPP | 2029-05-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-007 | PED | 2029-11-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-008 | NPP | 2029-05-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-008 | PED | 2029-11-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-010 | NS | 2029-05-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-010 | PED | 2029-11-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-011 | NS | 2029-05-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207947-011 | PED | 2029-11-23 | caaa826d4ba7… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207947-001 | ODE-106 | 2022-12-21 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207947-002 | ODE-106 | 2022-12-21 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207947-003 | ODE-106 | 2022-12-21 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207947-004 | ODE-106 | 2022-12-21 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207947-005 | ODE-106 | 2022-12-21 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207947-006 | ODE-106 | 2022-12-21 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207947-007 | ODE-106 | 2022-12-21 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207947-008 | ODE-106 | 2022-12-21 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N207947-001 | ODE-106 | 2022-12-21 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N207947-002 | ODE-106 | 2022-12-21 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N207947-003 | ODE-106 | 2022-12-21 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N207947-004 | ODE-106 | 2022-12-21 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N207947-005 | ODE-106 | 2022-12-21 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N207947-006 | ODE-106 | 2022-12-21 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N207947-007 | ODE-106 | 2022-12-21 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N207947-008 | ODE-106 | 2022-12-21 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N207947-001 | ODE-106 | 2022-12-21 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N207947-002 | ODE-106 | 2022-12-21 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N207947-003 | ODE-106 | 2022-12-21 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N207947-004 | ODE-106 | 2022-12-21 | 4b0b4de00fa7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| UPTRAVI | SELEXIPAG | Actelion Pharmaceuticals US, Inc. | a7a23b87-f892-4e2c-8e2e-ebf841220f90 | 2026-05-28 | Warnings, Adverse reactions | 207947 NDA207947 66215-612 66215-614 66215-606 66215-616 66215-608 66215-604 66215-602 66215-610 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 66215-602 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-602 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-602 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-602 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-602 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-602 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-602 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-602 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-602 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-602 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-602 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-604 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-604 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-604 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-604 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-604 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-604 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-604 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-604 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-604 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-604 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-604 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-606 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-606 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-606 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-606 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-606 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-606 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-606 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-606 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-606 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-606 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-606 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-608 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-608 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-608 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-608 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-608 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-608 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-608 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-608 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-608 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-608 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-608 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-610 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-610 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-610 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-610 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-610 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-610 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-610 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-610 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-610 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-610 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-610 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-612 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-612 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-612 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-612 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-612 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-612 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-612 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-612 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-612 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-612 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-612 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-614 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-614 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-614 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-614 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-614 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-614 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-614 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-614 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-614 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-614 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-614 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-616 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-616 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
| 66215-616 | UPTRAVI | Selexipag | Actelion Pharmaceuticals US, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 69121 | SUPPL | 2021-10-26 |
| 69114 | SUPPL | 2021-10-26 |
| 68447 | SUPPL | 2021-08-24 |
| 68426 | SUPPL | 2021-08-20 |
| 66048 | SUPPL | 2021-02-01 |
| 66041 | SUPPL | 2021-02-01 |
| 59920 | SUPPL | 2019-09-05 |
| 59914 | SUPPL | 2019-09-05 |
| 50906 | SUPPL | 2017-12-27 |
| 50845 | SUPPL | 2017-12-22 |
| 49895 | SUPPL | 2017-09-29 |
| 49881 | SUPPL | 2017-09-29 |
| 49078 | SUPPL | 2017-07-25 |
| 49054 | SUPPL | 2017-07-25 |
| 24529 | ORIG | 2016-01-28 |
| 23043 | ORIG | 2016-01-28 |
| 32866 | ORIG | 2015-12-22 |
| 19976 | ORIG | 2015-12-22 |